Abstract:Objective To evaluate the relevance of molecular alterations and histopathological subtypes of lung adenocarcinoma according to 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. Methods Mutations of epidermal growth factor receptor (EGFR) 18-21 exons ( E18-21 ),KRAS 12/13 codons and EML4-ALK fusion in 212 cases of lung adenocarcinoma which underwent complete tumor resection,were detected by immunohistochemistry,PCR-amplifying and gene sequencing.The relevance of the molecular alterations to histopathological subtypes based on the new classification and 2004 WHO classification were further characterized. Results Mutations of EGFR were observed in 49.6％ of lung adenocarcinomas,involving mainly E21 (52.4％,55/105 ) and E19 ( 36.2％,38/105). Mutations of KRAS were detected in 8％ cases of adenocarcinoma,involving mainly codon 12 (15/17). EML4-ALK fusions were found in 6.1％ of lung adenocarcinoma,the most common fusion mutation was type V1 ( E13; A20) (7/13),followed by type V3a/b ( E6a/b; A20) (4/13).Based on the new classification, 7/10 lepidic, 63.2％ (48/76) papillary, and 5/8 micropapillary predominant adenocarcinomas harbored EGFR mutations. EGFR mutations showed significant difference among different histological subtypes (P =0.008). KRAS mutations were most frequently found in invasive mucinous adenocarcinoma (1/2),followed by colloid predominant adenocarcinoma (3/7). There was siguificant difference of KRAS mutations among different histological subtypes ( P =0.003 ).EMLA-ALK fusions were most frequently found in the solid predominant with mucin production subtype ( 15.4％,6/39),followed by colloid predominant adenocarcinoma ( 1/7 ),and no significant difference of EMLA-ALK fusions was found among different histological subtypes ( P =0.181 ). Significant TTF-1 overexpression was observed in adenocarcinomas harbored EGFR mutations (P =0.008 ),and no or significantly lower level expression of TTF-1 was observed in adenocarcinomas harbored KRAS mutations (P =0.000). However,there was no association between TTF-1 expression and EML4-ALK fusions ( P =0.274 ). Based on the 2004 WHO classification,mutations of KRAS ( P =0.002 ) and EML4-ALK (P =0.000),rather than EGFR ( P =0.502),showed significant differences among different subtypes. According to both classification systems,the difference of " triple negative" adenocarcinomas was not significant among different subtypes ( P =0.684,P =0.449, respectively ). Conclusions The new classification, combined with TTF-1 immunomarker,can help to predict the molecular alterations of EGFR and KRAS genes,but can not indicate the EML4-ALK fusion in lung adenocarcinoma. Lepidic, papillary, and micropapillary predominant adenocarcinomas with TTF-1 expression are closely related to the presence of EGFR mutation,and invasive mucinous adenocarcinoma,while colloid predominant adenocarcinoma without TTF-1 expression is closely related to the presence of KRAS mutation.

2011 New Lung Adenocarcinoma Multidisciplinary Classification:imaging aspects

Changes of 2015 WHO Histological Classiifcation of Lung Cancer and the Clinical Signiifcance

Lung adenocarcinomas: correlation of computed tomography and pathology findings

Classification of different patterns of pulmonary adenocarcinomas

Prognostic Significance of the IASLC/ATS/ERS Classification in Chinese Patients—a Single Institution Retrospective Study of 292 Lung Adenocarcinoma

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Morphological Classification of Pre-Invasive Lesions and Early-Stage Lung Adenocarcinoma Based on CT Images.

The Earliest Stage of Lung Adenocarcinoma: the Pathological Diagnosis and Clinical Significance of Adenocarcinoma in Situ

The Morphological Changes of Bronchovascular Bundles Within Subsolid Nodules on HRCT Correlate with the New IASLC Classification of Adenocarcinoma.

Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification

Characteristics and Prognostic Analysis of 193 Patients with Special Type of Lung Adenocarcinoma

Prognostic and Predictive Value of the Novel Classification of Lung Adenocarcinoma in Patients with Stage IB.

Radiological imaging and pathological findings of small lung adenocarcinoma: a narrative review

Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas

Preoperative markers for identifying CT ≤2 cm solid nodules of lung adenocarcinoma based on image deep learning

Correlation of Survival and EGFR Mutation with Predominant Histologic Subtype According to the New Lung Adenocarcinoma Classification in Stage IB Patients

Risk Stratification Model for Patients with Stage I Invasive Lung Adenocarcinoma Based on Clinical and Pathological Predictors.

Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma (vol 8, pg 159, 2017)

Genomic and Immune Profiling of Pre-Invasive Lung Adenocarcinoma.